Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSC for Chronic Kidney Disease Stages 3-4
NCT05512988Phase 2Unknown
- Sponsor
- Tongji Hospital
- Start
- Apr 2021
- Primary completion
- Apr 2024
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in chronic kidney disease (CKD), sponsored by Tongji Hospital. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT05512988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05512988.